References
- Adler, N. E., & Newman, K. (2002). Socioeconomic disparities in health: Pathways and policies. Health Affairs, 21(2), 60–76. https://doi.org/10.1377/hlthaff.21.2.60.
- Ahern, J., Stuber, J., & Galea, S. (2007). Stigma, discrimination and the health of illicit drug users. Drug and Alcohol Dependence, 88(2-3), 188–196. https://doi.org/10.1016/j.drugalcdep.2006.10.014
- Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H. (2010). Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. The Lancet, 376(9738), 367–387. https://doi.org/10.1016/S0140-6736(10)60829-X
- Barry, C. L., McGinty, E. E., Pescosolido, B. A., & Goldman, H. H. (2014). Stigma, discrimination, treatment effectiveness, and policy: Public views about drug addiction and mental illness. Psychiatric Services, 65(10), 1269–1272. https://doi.org/10.1176/appi.ps.201400140
- Bartoli, F., Carra, G., Brambilla, G., Carretta, D., Crocamo, C., Neufeind, J., Baldacchino A., Humphris G., & Clerici, M. (2014). Association between depression and non-fatal overdoses among drug users: A Systematic review and meta-analysis. Drug and Alcohol Dependence, 134, 12–21. https://doi.org/10.1016/j.drugalcdep.2013.10.007
- Beer, L., Tie, Y., Padilla, M., & Shouse, R. L. (2019). Generalized anxiety disorder symptoms among persons with diagnosed HIV in the United States-2015-2016, Medical Monitoring Project. AIDS (London, England). https://doi.org/10.1097/QAD.0000000000002286.
- Bradford, J. B., Coleman, S., & Cunningham, W. (2007). HIV system navigation: An emerging model to improve HIV care access. AIDS Patient Care and STDs, 21(Suppl 1), S49–S58. https://doi.org/10.1089/apc.2007.9987
- Bruce, R. D., & Altice, F. L. (2007). Clinical care of the HIV-Infected drug user. Infectious Disease Clinics of North America, 21(1), 149–179. doi:10.1016/j.idc.2007.03.009.
- CDC. (2017). HIV Surveillance report, 2017. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2017-vol-29.pdf
- CDC. (2017). Reducing harms from injection drug use & opioid use disorder with syringe services programs.
- CDC. (2019). Behavioral and clinical characteristics of persons with diagnosed HIV infection–Medical Monitoring Project, United States, 2016 cycle (June 2016-May 2017). HIV Surveillance Special Report 21.
- CDC. (2020). HIV infection risk, prevention, and testing behaviors among persons who inject drugs—National HIV Behavioral Surveillance: Injection Drug Use, 23 U.S. Cities, 2018. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-special-report-number-24.pdf
- Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim J. G., Kumwenda J., Grinsztejn B., Pilotto J. H. S., Godbole S. V., Chariyalertsak S., Santos B. R., Mayer K. H., Hoffman I. F., Eshleman S. H., Piwowar-Manning E., Cottle L., Zhang X. C., … Team, H. S. (2016). Antiretroviral therapy for the prevention of HIV-1 transmission. New England Journal of Medicine, 375(9), 830–839. https://doi.org/10.1056/NEJMoa1600693
- Colasanti, J., Stahl, N., Farber, E. W., Del Rio, C., & Armstrong, W. S. (2017). An exploratory study to assess individual and structural level barriers associated with poor retention and re-engagement in care among persons living with HIV/AIDS. Journal of Acquired Immune Deficiency Syndromes, 74(Suppl 2), S113–S120. https://doi.org/10.1097/QAI.0000000000001242.
- Cranston, K., Alpren, C., John, B., Dawson, E., Roosevelt, K., Burrage, A., Bryant, J., Switzer, W. M., Breen, C., Peters, P. J., Stiles, T., Murray, A., Fukuda, H. D., Adih, W., Goldman, L., Panneer, N., Callis, B., Campbell, E. M., Randall, L., … DeMaria, A. (2019). Notes from the field: HIV diagnoses among persons who inject drugs - Northeastern Massachusetts, 2015-2018. MMWR. Morbidity and Mortality Weekly Report, 68(10), 253–254. https://doi.org/10.15585/mmwr.mm6810a6.
- Crepaz, N., Tang, T., Marks, G., Mugavero, M. J., Espinoza, L., & Hall, H. I. (2016). Durable viral suppression and transmission risk potential among persons with diagnosed HIV infection: United States, 2012-2013. Clinical Infectious Diseases, 63(7), 976–983. https://doi.org/10.1093/cid/ciw418.
- Cunningham, W. E., Weiss, R. E., Nakazono, T., Malek, M. A., Shoptaw, S. J., Ettner, S. L., & Harawa, N. T. (2018). Effectiveness of a peer navigation intervention to sustain viral suppression among HIV-positive men and transgender women released from jail: The LINK LA Randomized clinical Trial. JAMA Internal Medicine, 178(4), 542–553. https://doi.org/10.1001/jamainternmed.2018.0150
- DHHS. (2014). Computations for the 2014 annual update of the HHS poverty guidelines for the 48 contiguous states and the District of Columbia. https://aspe.hhs.gov/computations-2014-annual-update-hhs-poverty-guidelines-48-contiguous-states-and-district-columbia.
- DHHS. (2015). Poverty guidelines. https://aspe.hhs.gov/2015-poverty-guidelines
- DHHS. (2016) Computations for the 2016 poverty guidelines. https://aspe.hhs.gov/computations-2016-poverty-guidelines
- Gokhale, R., Weiser, J., Sullivan, P. S., Luo, Q., Shu, F., & Bradley, H. (2019). Depression prevalence, antidepressant treatment status, and association with sustained HIV viral suppression among adults living with HIV in care in the United States, 2009–2014. AIDS and Behavior. https://doi.org/10.1007/s10461-019-02613-6
- Golden, M. R., Lechtenberg, R., Glick, S. N., Dombrowski, J., Duchin, J., Reuer, J. R., Dhanireddy S., Neme S., & Buskin, S. E. (2019). Outbreak of human immunodeficiency virus infection among heterosexual persons who are living homeless and inject drugs – Seattle, Washington, 2018. MMWR. Morbidity and Mortality Weekly Report, 68(15), 344–349. https://doi.org/10.15585/mmwr.mm6815a2
- HHS. (2019). Guidelines for the use of antiretroviral agents in adults and adolescents with HIV.
- Kamarulzaman, A., & Altice, F. L. (2015). Challenges in managing HIV in people who use drugs. Current Opinion in Infectious Diseases, 28(1), 10–16. https://doi.org/10.1097/QCO.0000000000000125
- Knowlton, A. J., Eldred, L. J., Wilkinson, J. D., Shade, S. B., Bohnert, A. S., Yang, C., Wissow, L. S., & Purcell, D. W. (2010). Antiretroviral use among active injection-drug users: The role of patient-provider engagement and structural factors. AIDS Patient Care and STDs, 24(7), 421–428. https://doi.org/10.1089/apc.2009.0240
- Krakower, D. S., Oldenburg, C. E., Mitty, J. A., Wilson, I. B., Kurth, A. E., Maloney, K. M., Gallagher D., & Mayer, K. H. (2015). Knowledge, beliefs and practices regarding antiretroviral medications for HIV prevention: results from a survey of healthcare providers in New England. PLoS One, 10(7), e0132398. https://doi.org/10.1371/journal.pone.0132398
- Lewden, C., Chene, G., Morlat, P., Raffi, F., Dupon, M., Dellamonica, P., Pellegrin J-L., Katlama C., Dabis F., Leport C., & Agence Nationale de Recherches sur le Sida et les Hepatites Virales (2007). HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. JAIDS Journal of Acquired Immune Deficiency Syndromes, 46(1), 72–77. https://doi.org/10.1097/QAI.0b013e318134257a
- Lucas, G. M., Cheever, L. W., Chaisson, R. E., & Moore, R. D. (2001). Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes, 27(3), 251–259. https://doi.org/10.1097/00042560-200107010-00006 doi: 10.1097/00126334-200107010-00006
- Mehta, S. H., Kirk, G. D., Astemborski, J., Galai, N., & Celentano, D. D. (2010). Temporal trends in highly active antiretroviral therapy initiation among injection drug users in Baltimore, Maryland, 1996-2008. Clinical Infectious Diseases, 50(12), 1664–1671. https://doi.org/10.1086/652867
- Meyer, J. P., Althoff, A. L., & Altice, F. L. (2013). Optimizing care for HIV-Infected people who use drugs: evidence-based approaches to overcoming healthcare disparities. Clinical Infectious Diseases, 57(9), 1309–1317. https://doi.org/10.1093/cid/cit427
- Milloy, M. J., Kerr, T., Buxton, J., Rhodes, T., Guillemi, S., Hogg, R., Montaner J., & Wood, E. (2011). Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug Users. The Journal of Infectious Diseases, 203(9), 1215–1221. https://doi.org/10.1093/infdis/jir032
- Mugavero, M. J., Amico, K. R., Westfall, A. O., Crane, H. M., Zinski, A., Willig, J. H., Dombrowski J. C., Norton W. E., Raper J. L., Kitahata M. M., & Saag, M. S. (2012). Early retention in HIV care and viral load suppression: Implications for a test and treat approach to HIV prevention. JAIDS Journal of Acquired Immune Deficiency Syndromes, 59(1), 86–93. https://doi.org/10.1097/QAI.0b013e318236f7d2
- Nandi, A., Glass, T. A., Cole, S. R., Chu, H., Galea, S., Celentano, D. D., Kirk G. D., Vlahov D., Latimer W. W., & Mehta, S. H. (2010). Neighborhood poverty and injection cessation in a sample of injection drug Users. American Journal of Epidemiology, 171(4), 391–398. https://doi.org/10.1093/aje/kwp416
- Palepu, A., Tyndall, M., Yip, B., O'Shaughnessy, M. V., Hogg, R. S., & Montaner, J. S. (2003). Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use. JAIDS Journal of Acquired Immune Deficiency Syndromes, 32(5), 522–526. https://doi.org/10.1097/00126334-200304150-00009
- Peters, P. J., Pontones, P., Hoover, K. W., Patel, M. R., Galang, R. R., Shields, J., Blosser, S. J., Spiller, M. W., Combs, B., Switzer, W. M., Conrad, C., Gentry, J., Khudyakov, Y., Waterhouse, D., Owen, S. M., Chapman, E., Roseberry, J. C., & McCants, V. (2016). HIV infection linked to injection use of oxymorphone in Indiana, 2014-2015. New England Journal of Medicine, 375(3), 229–239. https://doi.org/10.1056/NEJMoa1515195.
- Smith-Rohrberg, D., Mezger, J., Walton, M., Bruce, R. D., & Altice, F. L. (2006). Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-Infected drug users. JAIDS Journal of Acquired Immune Deficiency Syndromes, 43(Suppl 1), S48–S53. https://doi.org/10.1097/01.qai.0000248338.74943.85.
- Spitzer, R. L., Kroenke, K., & Williams, J. B. (1999). Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA, 282(18), 1737–1744. 10.1001/jama.282.18.1737.
- Spitzer, R. L., Kroenke, K., Williams, J. B., & Lowe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092–1097. https://doi.org/10.1001/archinte.166.10.1092
- Strathdee, S. A., Patrick, D. M., Currie, S. L., Cornelisse, P. G., Rekart, M. L., Montaner, J. S., Schechter, M. T, & O'Shaughnessy, M. V. (1997). Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS (London, England), 11(8), F59–F65. https://doi.org/10.1097/00002030-199708000-00001.
- Sulkowski, M. S. (2007). Hepatitis C virus infection in HIV-infected patients. Current Infectious Disease Reports, 3(5), 469–476. https://doi.org/10.1007/s11908-007-1004-1.
- Westergaard, R. P., Ambrose, B. K., Mehta, S. H., & Kirk, G. D. (2012). Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: A survey of North American HIV providers. Journal of the International AIDS Society, 15(1), 10. https://doi.org/10.1186/1758-2652-15-10
- WHO. (2017). Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy.
- Wilson, N., Kariisa, M., Seth, P., Smith, H. T., & Davis, N. L. (2020). Drug and opioid-involved overdose deaths - United States, 2017-2018. MMWR. Morbidity and Mortality Weekly Report, 69(11), 290–297. https://doi.org/10.15585/mmwr.mm6911a4
- Zibbell, J. E., Asher, A. K., Patel, R. C., Kupronis, B., Iqbal, K., Ward, J. W., & Holtzman, D. (2018). Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004–2014. American Journal of Public Health, 108(2), 175–181. doi: 10.2105/AJPH.2017.304132